In early tumour development, CD4+ T cells are driven to differentiate as Tregs rather that effector CD4+ T cells in the TDLN, promoting suppressive Treg responses that mimic peripheral self-tolerance to tumour antigen. Here, CD4 is linked to neoplasm.